Tag: DPP-4

DPP-4 is better target to lower migraine rates in patients with type 2 diabetes

Presented By
Dr Chen Ting-Chuan, Taichung Veterans General Hospital, Taiwan
Conference
EHC 2024
Type
News article

6 January 2025 11:10

SGLT2 inhibition: A possible mode-of-action for inflammatory skin diseases?

Presented By
Allison Holt, UMass Chan Medical School, USA
Conference
AAD 2024
Type
Peer-reviewed article

22 April 2024 15:06

Empagliflozin linked to lower cardiovascular risk and renal events in real-world study

Presented By
Prof. Leo Niskanen, University of Eastern Finland, Finland
Conference
HFA 2021
Type
Peer-reviewed article

19 August 2021 09:43
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com